Barings’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Barings’s Portfolio CRTX Stock Details CRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-24,000	Closed	-$228K	–	974
2013 Q4	$228K	Buy	+24,000	New	+$227K	0.01%	827

Other funds holding CRTX

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Barings's CRTX Position: Q1 2014 in Review

Barings sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 24,000 shares — an estimated $228K sold.

Barings first reported a position in CRTX in Q4 2013 and held it in 1 quarter. The position peaked at $228K in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

Barings reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
Barings sold 24,000 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $228K.
Barings first reported a position in CORNERSTONE THERAPEUTICS INC in Q4 2013 and held it in 1 quarter.
Barings's CORNERSTONE THERAPEUTICS INC position peaked at $228K in Q4 2013.
1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Barings's 13F filing for Q1 2014, filed 12 May 2014.